# DoW Awards VeriSIM Life Modeling Agreement

The U.S. Department of War (DoW) awarded VeriSIM Life an agreement, announced September 28, to apply its BIOiSIM computational platform to medical countermeasure development and safety assessment. The work will evaluate how computational models can complement experimental data, improve translation of preclinical findings to humans, and reduce animal studies where scientifically appropriate. The announcement provides no contract value or performance timeline.

- The agreement is identified as contract **W911SR-26-9-A036** and involves the Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense and the Joint Project Lead for CBRN Enabling Technologies.
- For contractors and research organizations, the award signals DoW interest in evaluating computational modeling as a complement to experimental approaches in medical countermeasure R&D; relevant capabilities should be framed around those stated objectives.
- No solicitation, follow-on procurement, contract value, or performance timeline is provided, so the announcement does not establish a near-term bidding opportunity or a disclosed market size.

**Jurisdictions:** federal
**Industries:** Defense & Military, Healthcare
**Published:** September 29, 2026

### Government Entities
- United States Department of War (DoW)
- Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense (CPE CBRN Defense)
- Joint Project Lead for CBRN Enabling Technologies (JPL CBRN Enabling Technologies)

### Vendors
- VeriSIM Life (awardee)

### Sources
- [VeriSIM Life awarded US government agreement to advance drug development](https://t.co/zawwMsBzUH) - t.co